Objective: To evaluate the long-term effect of intravitreal triamcinolone acetonide (IVT) treatment combined with photodynamic therapy (PDT) vs PDT alone for neovascular age-related macular degeneration.Methods: Prospective randomized study. Eighty-four patients were enrolled to receive PDT (n=41) or IVT treatment followed by PDT (n=43) within approximately a 7-to 15day interval. All patients were naive to treatment. At baseline and each follow-up visit at 3, 6, 12, and 24 months, measurement of best-corrected visual acuity (VA), fluorescein angiography, indocyanine green angiography, and optical coherence tomography were performed. Mean changes in VA and retreatment rate were considered as primary outcomeindicators.Analysisofvascularchoroidalchangesdocumented by indocyanine green angiography and fundus autofluorescence measurements were also performed.
Results:Mean VA increased at 1 month of follow-up but decreased progressively by the 24-month point in both groups (P=.74). The retreatment rate was significantly lower (P Ͻ .001) in the combined therapy group. Choroidal hypoperfusion/nonperfusion (PϽ.001) and areas with decreased/absent fundus autofluorescence within the PDT spot area were significantly greater with combined therapy (PϽ .001).
Conclusions:Combination IVT treatment with PDT seemed to be more effective for managing neovascular age-related macular degeneration, but long-term analysis failed to demonstrate functional benefits.